Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Monsieurs

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Nuclear Medicine Communications|May 8, 2001
Patient dosimetry after 131I-MIBG therapy for neuroblastoma and carcinoid tumoursM A Monsieurs, H M Thierens, A Vral, et al.
Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society|January 4, 2001
Dosimetry from organ to cellular dimensionsH M Thierens, M A Monsieurs, B Brans, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2000
Adaptive response in patients treated with 131IM A Monsieurs, H M Thierens, A M Vral, et al.
Nuclear Medicine Communications|October 21, 1999
Estimation of risk based on biological dosimetry for patients treated with radioiodineM A Monsieurs, H M Thierens, C V van de Wiele, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Nuclear Medicine Communications|May 8, 2001
Patient dosimetry after 131I-MIBG therapy for neuroblastoma and carcinoid tumoursM A Monsieurs, H M Thierens, A Vral, et al.
Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society|January 4, 2001
Dosimetry from organ to cellular dimensionsH M Thierens, M A Monsieurs, B Brans, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2000
Adaptive response in patients treated with 131IM A Monsieurs, H M Thierens, A M Vral, et al.
Nuclear Medicine Communications|October 21, 1999
Estimation of risk based on biological dosimetry for patients treated with radioiodineM A Monsieurs, H M Thierens, C V van de Wiele, et al.
Pageof 1